Senescence-Associated β-Galactosidase Detection in Pathology.

Area of Science:

• Cellular Biology
• Oncology
• Biotechnology

Background:

• Cellular senescence is a stable cell cycle arrest, acting as a tumor suppression mechanism akin to apoptosis.
• Senescence-associated β-galactosidase (SA-β-gal) activity at pH 6 is a classic marker for cellular senescence.
• SA-β-gal is implicated in malignant cell transformation and elevated in various cancerous and benign lesions.

Purpose of the Study:

• To review and analyze clinical and biological data on SA-β-gal.
• To support the wider implementation of SA-β-gal in medical diagnostics.
• To highlight the potential of SA-β-gal in visualizing tumor margins and metastases.

Main Methods:

• Literature review of existing clinical and biological data on SA-β-gal.
• Analysis of SA-β-gal's role in cellular senescence and tumor progression.
• Exploration of SA-β-gal as a diagnostic and therapeutic target.

Main Results:

• High SA-β-gal levels are observed in various cancers and benign lesions.
• SA-β-gal is a promising marker for visualizing tumor margins and metastases.
• Therapy-induced senescence utilizing SA-β-gal is a potential therapeutic strategy.

Conclusions:

• SA-β-gal is a valuable biomarker for cellular senescence with significant diagnostic potential in oncology.
• Further research and data analysis are needed to integrate SA-β-gal into routine medical diagnostics.
• SA-β-gal is relevant for pathologists, biologists, and biotechnologists in regenerative medicine and cancer research.